APO2 ligand: A novel lethal weapon against malignant glioma?

FEBS Letters

Volumn 427, Issue 1, 1998, Pages 124-128

  Rieger, Johannes ^a   Naumann, Ulrike ^a   Glaser, Tamara ^a   Ashkenazi, Avi ^b   Weller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GENENTECH INC   (United States)

Author keywords

APO2 ligand; Apoptosis; Human glioma cell

Indexed keywords

CYTOKINE; DEXAMETHASONE; FAS ANTIGEN; LIPOXYGENASE INHIBITOR; NORDIHYDROGUAIARETIC ACID;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE TARGETING; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; GLIOMA; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032079348     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00409-8     Document Type: Article

References (24)

1. Weller M., Frei K., Groscurth P., Krammer P.H., Yonekawa Y., Fontana A. J. Clin. Invest. 94:1994;954-964.
2. Weller, M., Kleihues, P., Dichgans, J. and Ohgaki, H. (1998) Brain Pathol. (in press).
3. Pitti R.M., Marsters S.A., Ruppert S., Donahue C.J., Moore A., Ashkenazi A. J. Biol. Chem. 271:1996;12687-12690.
4. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.-P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A., Goodwin R.G. Immunity. 3:1995;673-682.
5. Pan G., O'Rourke K., Chinnaiyan A.M., Gentz R., Ebner R., Ni J., Dixit V.M. Science. 276:1997;111-113.
6. Sheridan J.P., Marsters S.A., Pitti R.M., Gurney A., Skubatch M., Baldwin D., Ramakrishnan L., Gray C.L., Baker K., Wood W.I., Goddard A.D., Godowski P., Ashkenazi A. Science. 277:1997;818-821.
7. Pan G., Ni N., Wei Y.-F., Yu G.-L., Gentz R., Dixit V.M. Science. 277:1997;815-818.
8. Chaudhary P.M., Eby M., Jasmin A., Bookwalter A., Murray J., Hood L. Immunity. 7:1997;821-830.
9. Schneider P., Thome M., Burns K., Bodmer J.-L., Hofmann K., Kataoka T., Holler N., Tschopp J. Immunity. 7:1997;831-836.
10. Marsters S.A., Pitti R.M., Donahue C.J., Ruppert S., Bauer K.D., Ashkenazi A. Curr. Biol. 6:1996;750-750.
11. Mariani S.M., Matiba B., Armandola E.A., Krammer P.H. J. Cell Biol. 137:1997;221-229.
12. Marsters S.A., Sheridan J.P., Pitti R.M., Huang A., Skubatch M., Baldwin D., Yuan J., Gurney A., Goddard A.D., Godowski P., Ashkenazi A. Curr. Biol. 7:1997;1003-1006.
13. Degli-Esposti M.A., Dougall W.C., Smolak P.J., Waugh J.Y., Smith C.A., Goodwin R.G. Immunity. 7:1997;813-820.
14. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Nature. 364:1993;806-809.
15. Roth, W., Fontana, A., Trepel, M., Dichgans, J., Reed, J.C. and Weller, M. Cancer Immunol. Immunother. 44, 55-63.
16. Weller M., Malipiero U., Aguzzi A., Reed J.C., Fontana A. J. Clin. Invest. 95:1995;2633-2643.
17. Trepel, M., Groscurth, P., Malipiero, U., Gulbins, E., Dichgans, J. and Weller, M. (1998) J. Neuro-Oncol. (in press).
18. Strasser A., Harris A.W., Huang D.C., Krammer P.H., Cory S. EMBO J. 14:1995;6136-6147.
19. Weller M., Trepel M., Grimmel C., Schabet M., Bremen D., Krajewski S., Reed J.C. Neurol. Res. 19:1997;459-470.
20. Weller M., Malipiero U., Rensing-Ehl A., Barr P.J., Fontana A. Cancer Res. 55:1995;2936-2944.
21. Roth W., Wagenknecht B., Grimmel C., Dichgans J., Weller M. Br. J. Cancer. 77:1998;404-411.
22. Wagenknecht B., Gulbins E., Lang F., Dichgans J., Weller M. FEBS Lett. 409:1997;17-23.
23. Van Meir E.G., Kikuchi T., Tada T., Li H., Diserens A.C., Wojcik B.E., Huang H.J.S., Friedmann T., De Tribolet N., Cavenee W.K. Cancer Res. 54:1994;649-652.
24. Wu G.S., Burns T.F., McDonald E.R., Jiang W., Meng R., Krantz I.D., Kao G., Gan D.D., Zhou J.Y., Muschel R., Hamilton S.R., Spinner N.B., Markowitz S., Wu G., Deiry W.S. Nature Genet. 17:1997;141-143.